These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6680023)

  • 1. Normal response to uraemic platelets to thromboxane A2 agonist.
    Soszka J; Rydzewski A; Myśliwiec M
    Nephron; 1983; 35(4):267-8. PubMed ID: 6680023
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of [3H]9,11-dideoxy,9 alpha-11 alpha-methanoepoxy prostaglandin F2 alpha (U 46619) to washed human platelets.
    Jaschonek K; Faul C; Weisenberger H; Schmidt H; Renn W
    Prog Clin Biol Res; 1989; 301():327-33. PubMed ID: 2529551
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor.
    Gillard JW; Morton HE; Fortin R; Yoakim C; Girard Y; Lord A; Ethier D; Leveille C; Letts G; Evans J
    Prog Clin Biol Res; 1989; 301():579-83. PubMed ID: 2529557
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids.
    Lagarde M; Boutillon MM; Guichardant M; Lellouche JP; Beaucourt JP; Vanhove A; Grée R
    Biochem Pharmacol; 1989 Jun; 38(11):1863-4. PubMed ID: 2735941
    [No Abstract]   [Full Text] [Related]  

  • 7. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation induced by a stable analogue of endoperoxides (U46619).
    Zatta A; Prosdocimi M
    Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.
    Mayo JR; Navran SS; Huzoor-Akbar ; Miller DD; Feller DR
    Biochem Pharmacol; 1981 Aug; 30(16):2237-41. PubMed ID: 7188564
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of endoperoxide analog-induced platelet aggregation by heparin.
    Mehta P; Mehta J
    Thromb Res; 1982 Jan 1-15; 25(1-2):91-9. PubMed ID: 7064132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitisation in human and rabbit blood platelets.
    Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
    Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.
    Furlong B; Henderson AH; Lewis MJ; Smith JA
    Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivo.
    Watts IS; White BP; Wharton KA; Lumley P
    Br J Pharmacol; 1989 Dec; 98 Suppl():842P. PubMed ID: 2611538
    [No Abstract]   [Full Text] [Related]  

  • 14. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK; Ullian ME; Halushka PV
    J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619.
    Huang EM; Detwiler TC
    Biochim Biophys Acta; 1982 Apr; 715(2):246-9. PubMed ID: 6803846
    [No Abstract]   [Full Text] [Related]  

  • 16. The cyclic AMP-lowering effect on the stable endoperoxide analog U46619 in human platelets.
    Bonne C; Martin B; Regnault F
    Thromb Res; 1980 Dec 1-15; 20(5-6):701-4. PubMed ID: 6262941
    [No Abstract]   [Full Text] [Related]  

  • 17. [Increased adhesive and aggregation activity of the platelets of ischemic heart disease patients with stable stenocardia].
    Sinitsyn VE; Mazurov AV; Liakishev AA; Sidorenko BA; Repin VS
    Kardiologiia; 1987 Feb; 27(2):96-7. PubMed ID: 3573534
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.